NCT02604251已完成不适用
A Prospective Randomized Clinical Study Evaluating the Safety and Efficacy of the KLOX BioPhotonic WoundGel System When Compared With Silicone Sheets in the Treatment of Surgical Wounds
KLOX Technologies Inc.4 个研究点 分布在 1 个国家目标入组 42 人开始时间: 2015年10月1日最近更新:
适应症
干预措施
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 42
- 试验地点
- 4
- 主要终点
- Adverse Events, Serious Adverse Events and Device Incidents
研究概览
简要总结
This is a multicenter, randomized, prospective, controlled study in patients having bilateral breast reduction. Objectives of the study are to evaluate the safety and efficacy of the KLOX BioPhotonic WoundGel System compared with the ones of Silicone Sheets in the treatment of surgical wounds.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 75 Years（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Signed and dated written informed consent form
- •Female patients, aged between 18 and 75 years old
- •Good general health, stable weight, free of systemic diseases such as diabetes, arthritis, HIV infection or genetic disorder that could influence the outcome of the treatment
- •Fitzpatrick skin type I to IV
- •Patients scheduled to go through bilateral breast reduction and expected to have newly formed post-surgery breast incisions of comparable length, located on comparable skin area
- •Patients able to understand, willing and able to comply with all study requirements
- •Patients must either be incapable of reproduction, or taking acceptable measures to prevent pregnancy and have a negative pregnancy test prior to participation in the Study
- •Females of childbearing potential must not be lactating at Study Screening and agree to use adequate contraceptive method during the Study
排除标准
- •Inability to understand the Study and its requirements or to give informed consent
- •Patient has participated in any other clinical study within 3 months prior to Study Screening and throughout the Study duration
- •Systemic antibiotic therapy or anti-inflammatory drugs or any other medication(s) that might interfere with healing within the last three months prior to Study Screening and throughout the Study duration
- •Current use of anticoagulants such as (but not limited to) warfarin, clopidogrel, enoxaparin or high doses of aspirin (> 162 mg daily)
- •Patient with current alcohol use or actively consuming drugs (addiction) as it may interfere with patient's ability to comply with Study procedures
- •Female patient pregnant, nursing or planning to become pregnant within the next 18 months
- •Patient is a current smoker or has been smoking or using nicotine product(s) in the last three months
- •Patient with known photosensitivity, taking drug(s) to treat photosensitivity, with concurrent disease (such as porphyria) or drug(s) (such as methotrexate or chloroquine) known to induce severe photosensitivity of the skin
- •Patients who are immunocompromised or taking immunosuppressive therapy
- •Any concurrent therapy that, in the investigator's opinion, would interfere with the evaluation of the safety or efficacy of the Study investigational device
- •Patient has ongoing malignant disease of any type, active systemic, local skin infection or disease, autoimmune disease or any significant chronic disease which, in the opinion of the investigator, might interfere with the evaluation of the Study objectives or would result in non-compliance with the Study protocol
- •Patients with known hypersensitivity to pain medications
- •Patients with severe elastosis
- •Patients with severe or cystic acne on the area(s) to be treated
- •Presence of a metal stent or implant in the area(s) to be treated
- •Patients with derma resurfacing procedures or non-invasive skin-tightening procedures including medium/deep chemical peeling, microdermabrasion, laser therapy or prescription level glycolic acid treatment to the treatment area(s) within three months prior to Study Screening or during the Study
- •Patients anticipating the need for surgery or overnight hospitalization during the course of the Study
- •Patients with history of keloids or hypertrophic scars
- •Patients anticipating sun tanning bed or excessive sun exposure during the Study period
- •Patients with significant breast asymmetry that may result in asymmetrical operative incisions being made on the left and right breasts
- •Patients with breast asymmetry that may result in different post-operative tensions on the wounds of the left and right breasts
- •Patients having had surgery in the area to be incised within one year of Study Screening
- •Patients with tattoos in the areas of incisions
- •Patients with incisions that are actively bleeding
- •Patients with history of irradiated breast(s) in the area(s) to be treated.
研究组 & 干预措施
Treatment with KLOX BioPhotonic WoundGel System
Experimental
One breast will be randomized to be treated with KLOX BioPhotonic WoundGel System.
干预措施: KLOX BioPhotonic WoundGel System (Device)
Treatment with silicone sheets
Active Comparator
The second breast will be randomized to be treated with silicone sheets.
干预措施: Silicone sheets (Device)
结局指标
主要结局
Adverse Events, Serious Adverse Events and Device Incidents
时间窗: 24 weeks
Number of patients with adverse events, serious adverse events and device incidents
次要结局
- Efficacy as assessed by blinded experts panel(up to 24 weeks)
- Patient and Observer Scar Assessment Scale (POSAS)(up to 24 weeks)
- Vancouver Scar Scale (VSS)(up to 24 weeks)
- Ease of wound management(up to 24 weeks)
研究者
研究点 (4)
Loading locations...
相似试验
Unknown
2 期
Treatment of EGFR-TKI for Residual Lesions of Multiple Synchronous Ground-glass OpacitiesMultiple Primary Lung CancersNCT04982900Ruijin Hospital138
进行中（未招募）
2 期
A Study Evaluating the Safety and Efficacy of Tirofiban in Combination With Alteplase in Acute Ischemic StrokeAcute Ischemic StrokeNCT05188417GrandPharma (China) Co., Ltd.266
招募中
不适用
A Clinical Study on the Efficacy and Safety of Xuanfei Baidu Granule in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary DiseaseAcute Exacerbation of Chronic Obstructive Pulmonary DiseaseNCT06134063Peking University People's Hospital375
招募中
3 期
Comparison Study of EAP and Disease-Specific Chemotherapy Regimens in Hematopoietic Stem Cell Mobilization for LymphomaNon-Hodgkin's LymphomaHematopoietic Stem Cell MobilizationNCT06520163The Affiliated People's Hospital of Ningbo University99
已完成
不适用
A Study of Hyaluronate Injectable Viscosupplement for Treatment of Osteoarthritis of the KneeOsteoarthritisNCT02495857Actavis Inc.599